David Wichlan

Employing a Gain-of-Function Factor IX Variant R338L to Advance the Efficacy and Safety of Hemophilia B Human Gene Therapy: Preclinical Evaluation Supporting an Ongoing Adeno-Associated Virus Clinical Trial

Paul E. Monahan, Junjiang Sun, Tong Gui et al. · Human Gene Therapy · 2014 · 107 citations · Full text

Immunology, Pathology, Empty Aav Particles +16

Human CD4+CD25+ Regulatory T Cells Share Equally Complex and Comparable Repertoires with CD4+CD25− Counterparts

Kimberly A. Kasow, Xiaohua Chen, James Knowles et al. · The Journal of Immunology · 2004 · 89 citations · Full text

Comparable Repertoires, Lymphocyte Development, Adaptive Immune System +21

Prospective Analysis of <i>TEL</i> Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Jeffrey E. Rubnitz, David Wichlan, Meenakshi Devidas et al. · Journal of Clinical Oncology · 2008 · 84 citations · Full text

Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup

Jeffrey E. Rubnitz, F G Behm, David Wichlan et al. · Leukemia · 1999 · 81 citations

Hematological Malignancy, Oncology, Health Sciences +11

Identification of an early-stage gene of Chlamydia psittaci 6BC

David Wichlan, T P Hatch · Journal of Bacteriology · 1993 · 73 citations · Full text

Genetics, Bacteriology, Molecular Biology +18